|
Market Closed -
Bombay S.E.
06:21:15 2026-08-21 am EDT
|
5-day change | 1st Jan Change | ||
| 96.00 INR | -0.40% |
|
+13.99% | +133.75% |
| Market Cap | 18.52B 194M 166M 155M 142M 267M 270M 1.83B 715M 9.3B 727M 711M 30.77B | P/E 2024 |
22.4x | P/E 2025 | 21.8x |
|---|---|---|---|---|---|
| Enterprise Value | 18.52B 194M 166M 155M 142M 267M 270M 1.83B 715M 9.3B 727M 711M 30.77B | EV / Sales 2024 |
1.27x | EV / Sales 2025 | 1.45x |
| Free-Float |
57.31% | Yield 2024 * |
-
| Yield 2025 | 0.42% |
| 1 day | -0.40% | ||
| 1 week | +13.99% | ||
| Current month | +68.42% | ||
| 1 month | +80.21% | ||
| 3 months | +123.78% | ||
| 6 months | +144.21% | ||
| Current year | +133.75% |
| 1 week | 83.16 |  | 97.46 |
| 1 month | 51.43 | | 97.46 |
| Current year | 33.44 | | 97.46 |
| 1 year | 33.44 | | 97.46 |
| 3 years | 31.31 | | 100.8 |
| 5 years | 23.65 | | 100.8 |
| 10 years | 7.21 | | 100.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sushil Suri
CEO | Chief Executive Officer | 62 | 1992-01-31 |
Sanjay Suri
CEO | Chief Executive Officer | 58 | 2026-06-30 |
| Director of Finance/CFO | 59 | 2002-04-02 |
| Director | Title | Age | Since |
|---|---|---|---|
Sushil Suri
CHM | Chairman | 62 | 1992-01-31 |
| Director/Board Member | 58 | 2019-08-12 | |
Savita
BRD | Director/Board Member | - | 2020-06-21 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.40% | +13.99% | +95.80% | +154.24% | 550M | |
| +0.88% | +6.38% | +76.40% | +126.75% | 1,119B | |
| +1.07% | +3.80% | +50.73% | +62.78% | 651B | |
| +1.20% | +6.21% | +25.81% | +78.74% | 468B | |
| +1.02% | +5.77% | +43.63% | +48.43% | 374B | |
| +0.85% | +4.07% | +24.97% | +40.58% | 302B | |
| +1.26% | +6.81% | +2.27% | +14.41% | 259B | |
| +1.88% | +5.81% | +49.57% | +70.53% | 238B | |
| +1.59% | +2.09% | -17.33% | -52.62% | 208B | |
| +1.87% | +5.61% | +27.32% | +91.38% | 181B | |
| Average | +1.12% | +5.88% | +37.92% | +63.52% | 380.04B | |
| Weighted average by Cap. | +1.14% | +5.09% | +44.27% | +72.66% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 17.02B 178M 152M 143M 131M 245M 248M 1.68B 657M 8.55B 668M 653M 28.28B | 18.12B 189M 162M 152M 139M 261M 264M 1.79B 699M 9.1B 711M 695M 30.1B |
| Net income | 962M 10.05M 8.61M 8.06M 7.37M 13.84M 14.02M 95.17M 37.11M 483M 37.74M 36.92M 1.6B | 1.18B 12.34M 10.57M 9.89M 9.05M 16.98M 17.21M 117M 45.55M 593M 46.32M 45.31M 1.96B |
| Net Debt | 121M 1.26M 1.08M 1.01M 924K 1.73M 1.76M 11.93M 4.65M 60.55M 4.73M 4.63M 200M | -928K -9.7K -8.31K -7.77K -7.12K -13.35K -13.53K -91.85K -35.82K -466K -36.42K -35.63K -1.54M |
Employees
1,814
Sector
Pharmaceuticals
Calendar
Sep. 18
Ex-dividend date - 0.2 INR
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-21 | ₹96.00 | -0.40% | 1,247,873 |
| 26-08-20 | ₹96.39 | +9.00% | 2,658,128 |
| 26-08-19 | ₹88.43 | +0.08% | 575,568 |
| 26-08-18 | ₹88.36 | -1.64% | 1,824,674 |
| 26-08-17 | ₹89.83 | +6.66% | 2,993,998 |
- Stock Market
- Stocks
- MOREPENLAB Stock
Select your edition
All financial news and data tailored to specific country editions
